4//SEC Filing
Friedman Charlene A 4
Accession 0001181431-13-005436
CIK 0001401923other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 7:52 PM ET
Size
12.7 KB
Accession
0001181431-13-005436
Insider Transaction Report
Form 4
Friedman Charlene A
VP President, Gen Counsel &Sec
Transactions
- Exercise/Conversion
Common Stock
2013-01-26+2,250→ 5,100 total - Tax Payment
Common Stock
2013-01-25$24.75/sh−1,207$29,873→ 2,850 total - Exercise/Conversion
Common Stock
2013-01-26−2,250→ 4,500 total→ Common Stock (2,250 underlying) - Exercise/Conversion
Common Stock
2013-01-25+2,750→ 4,057 total - Exercise/Conversion
Common Stock
2013-01-25−2,750→ 8,250 total→ Common Stock (2,750 underlying) - Tax Payment
Common Stock
2013-01-26$24.75/sh−871$21,557→ 4,229 total
Footnotes (3)
- [F1]Each RSU represents a contingent right to receive one share of MAP common stock.
- [F2]25% of the total number of RSU granted on January 25, 2012 vested on January 25, 2013.
- [F3]25% of the total number of RSU granted on January 26, 2011 vested on January 26, 2013.
Documents
Issuer
MAP Pharmaceuticals, Inc.
CIK 0001401923
Entity typeother
Related Parties
1- filerCIK 0001413748
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 7:52 PM ET
- Size
- 12.7 KB